These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 6223402

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. The efficacy of a low-dose, monodisperse parasympathicolytic aerosol compared with a standard aerosol from a metered-dose inhaler.
    Zanen P, Go LT, Lammers JW.
    Eur J Clin Pharmacol; 1998 Mar; 54(1):27-30. PubMed ID: 9591926
    [Abstract] [Full Text] [Related]

  • 23. A single dose comparison of a combination of fenoterol and ipratropium aerosols in bronchial asthma.
    Lawford P, Palmer KN.
    Postgrad Med J; 1983 Jan; 59(687):28-30. PubMed ID: 6223289
    [Abstract] [Full Text] [Related]

  • 24. Additive effects of isoproterenol-phenylephrine aerosol following ipratropium bromide on airway obstruction in older patients with intrinsic asthma and chronic bronchitis.
    Fujimura M, Azuma H, Uotani K, Mifune J, Tanaka T, Matsuda T.
    Jpn J Med; 1986 May; 25(2):122-6. PubMed ID: 2943921
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Single-dose comparison of salbutamol and Duovent-Berodual in asthma.
    Crane J.
    Respiration; 1986 May; 50 Suppl 2():285-9. PubMed ID: 2951823
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Therapeutic equivalence of a fenoterol/ipratropium bromide combination (Berodual) inhaled as a dry powder and by metered dose inhaler in chronic obstructive airway disease.
    Rammeloo RH, Luursema PB, Sips AP, Beumer HM, Wald FD, Cornelissen PJ.
    Respiration; 1992 May; 59(6):322-6. PubMed ID: 1488568
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Clearance of lung secretions in patients with chronic bronchitis: effect of terbutaline and ipratropium bromide aerosols.
    Pavia D, Bateman JR, Sheahan NF, Clarke SW.
    Eur J Respir Dis; 1980 Oct; 61(5):245-53. PubMed ID: 6451446
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Ipratropium bromide (Atrovent) as inhalation powder. A double-blind study of comparison with ipratropium as a pressure aerosol in patients with reversible airways obstruction.
    Maesen FP, Smeets JJ, Bernsen R, Cornelissen PJ.
    Allergy; 1986 Jan; 41(1):37-42. PubMed ID: 2938515
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Airways responses to ipratropium bromide do not vary with time in asthmatic subjects. Studies of interindividual and intraindividual variation of bronchodilatation and protection against histamine-induced bronchoconstriction.
    Ihre E, Larsson K.
    Chest; 1990 Jan; 97(1):46-51. PubMed ID: 2136826
    [Abstract] [Full Text] [Related]

  • 40. Bronchodilator reversibility to low and high doses of terbutaline and ipratropium bromide in patients with chronic obstructive pulmonary disease.
    Newnham DM, Dhillon DP, Winter JH, Jackson CM, Clark RA, Lipworth BJ.
    Thorax; 1993 Nov; 48(11):1151-5. PubMed ID: 8296260
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.